William J. Newell
2018
In 2018, William J. Newell earned a total compensation of $8.7M as Chief Executive Officer at SUTRO BIOPHARMA, a 1,136% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $301,250 |
|---|---|
| Option Awards | $6,764,993 |
| Salary | $482,000 |
| Stock Awards | $1,136,355 |
| Total | $8,684,598 |
Newell received $6.8M in option awards, accounting for 78% of the total pay in 2018.
Newell also received $301.3K in non-equity incentive plan, $482K in salary and $1.1M in stock awards.
Rankings
In 2018, William J. Newell's compensation ranked 905th out of 14,244 executives tracked by ExecPay. In other words, Newell earned more than 93.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 905 out of 14,244 | 94th |
Division Manufacturing | 302 out of 5,759 | 95th |
Major group Chemicals And Allied Products | 91 out of 2,122 | 96th |
Industry group Drugs | 70 out of 1,811 | 96th |
Industry Biological Products, Except Diagnostic Substances | 20 out of 339 | 94th |
Source: SEC filing on April 25, 2019.
Newell's colleagues
We found two more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2018.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019